share_log
Reuters ·  01/08 05:20

Maze Therapeutics - Matrix Capital Management Master Fund LP Beneficially Owned 7.1% of Common Shares Prior to Offering

Maze Therapeutics - Matrix Capital Management Master Fund LP 在增发前拥有7.1%的普通股权益

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发